Research News Infliximab biosimilars are safe, effective, and cheap, UK audit shows BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i5084 (Published 22 September 2016) Cite this as: BMJ 2016;354:i5084 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Physician associates: Direct instruction is a more appropriate term than supervision BMJ May 29, 2025, 389 r1096; DOI: https://doi.org/10.1136/bmj.r1096 Scarlett McNally: Small changes make a big difference in helping women doctors thrive BMJ May 28, 2025, 389 r1067; DOI: https://doi.org/10.1136/bmj.r1067 John Launer: Botox, lifestyle medicine, and future general practice BMJ May 28, 2025, 389 r1078; DOI: https://doi.org/10.1136/bmj.r1078 Helen Salisbury: Waiting for the 10 year plan BMJ May 28, 2025, 389 r1090; DOI: https://doi.org/10.1136/bmj.r1090 Matt Morgan: The dangers of main character syndrome in healthcare BMJ May 27, 2025, 389 r1081; DOI: https://doi.org/10.1136/bmj.r1081
